ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A. K.
Right arrow Articles by Sanofsky, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A. K.
Right arrow Articles by Sanofsky, S. J.

The Annals of Thoracic Surgery, Vol 54, 538-540, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Long-term results of St. Jude Medical valve in the tricuspid position

AK Singh, WC Feng and SJ Sanofsky
Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence.

Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
R. J. Shemin
Tricuspid Valve Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1111 - 1128.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho
Long-Term Clinical Results of Tricuspid Valve Replacement
Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
Y. Sakamoto, K. Hashimoto, H. Okuyama, S. Ishii, T. Inoue, and K. Kinouchi
Long-Term Results of Triple-Valve Procedure
Asian Cardiovasc Thorac Ann, February 1, 2006; 14(1): 47 - 50.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
N. A G Solomon, R. C H Lim, P. Nand, and K. J Graham
Tricuspid Valve Replacement: Bioprosthetic or Mechanical Valve?
Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 143 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Kalangos, J. Sierra, M. Beghetti, P. Trigo-Trindade, D. Vala, and J. Christenson
Tricuspid valve replacement with a mitral homograft in children with rheumatic tricuspid valvulopathy
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1682 - 1687.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. J. Shemin
Tricuspid Valve Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 1001 - 1015.
[Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Kawano, T. Oda, S. Fukunaga, E. Tayama, T. Kawara, A. Oryoji, and S. Aoyagi
Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience
Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 565 - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Sugimoto, M. Okada, N. Ozaki, T. Hatakeyama, and T. Kawahira
LONG-TERM EVALUATION OF TREATMENT FOR FUNCTIONAL TRICUSPID REGURGITATION WITH REGURGITANT VOLUME: CHARACTERISTIC DIFFERENCES BASED ON PRIMARY CARDIAC LESION
J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 463 - 471.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor
Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses
Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. T. Bajzer, W. J. Stewart, D. M. Cosgrove, S. J. Azzam, K. L. Arheart, and A. L. Klein
Tricuspid valve surgery and intraoperative echocardiography: Factors affecting survival, clinical outcome, and echocardiographic success
J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. E. Scully and C. S. Armstrong
Tricuspid valve replacement: Fifteen years of experience with mechanical prostheses and bioprostheses
J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1035 - 1041.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Nakano, H. Koyanagi, A. Hashimoto, G. Ohtsuka, and C. Nojiri
Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 888 - 892.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.